FLEXION THERAPEUTICS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 2, 2017 3.375% Convertible Senior Notes due 2024Indenture • May 2nd, 2017 • Flexion Therapeutics Inc • Pharmaceutical preparations • New York
INDENTURE dated as of May 2, 2017 between Flexion Therapeutics, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and Wells Fargo Bank, National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
CONSENT AND SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • May 2nd, 2017 • Flexion Therapeutics Inc • Pharmaceutical preparations • Maryland
CONSENT AND SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this “Agreement”) is dated as of April 24, 2017, and is effective as of the Consent Effective Date (as defined in in Section 6), by and among FLEXION THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the financial institutions or other entities from time to time parties thereto as lenders (the “Lenders”), and MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as Agent (in such capacity, “Agent”).
